References
Selleng K, Warkentin TE, Greinacher A (2007) Heparin-induced thrombocytopenia in intensive care patients. Crit Care Med 35:1165–1176
Lubenow N, Eichler P, Lietz T, Greinacher A, Hit Investigators G (2005) Lepirudin in patients with heparin-induced thrombocytopenia—results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3. J Thromb Haemost 3:2428–2436
Hacquard M, de Maistre E, Lecompte T (2005) Lepirudin: is the approved dosing schedule too high? J Thromb Haemost 3:2593–2596
Tardy B, Lecompte T, Boelhen F, Tardy-Poncet B, Elalamy I, Morange P, Gruel Y, Wolf M, Francois D, Racadot E, Camarasa P, Blouch MT, Nguyen F, Doubine S, Dutrillaux F, Alhenc-Gelas M, Martin-Toutain I, Bauters A, Ffrench P, de Maistre E, Grunebaum L, Mouton C, Huisse MG, Gouault-Heilmann M, Lucke V (2006) Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin. Blood 108:1492–1496
Warkentin TE (2004) Heparin-induced thrombocytopenia: diagnosis and management. Circulation 110:e454–e458
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wallet, F., Bayle, F., Leray, V. et al. Thrombosis during lepirudin therapy: a case report. Intensive Care Med 35, 959–960 (2009). https://doi.org/10.1007/s00134-008-1359-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-008-1359-2